Exploring the P-glycoprotein binding cavity with polyoxyethylene alkyl ethers

Biophysical Journal

Volumn 99, Issue 11, 2010, Pages 3589-3598

  Li Blatter, Xiaochun ^a   Seelig, Anna ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649834084     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.10.033     Document Type: Article

References (41)

1. Raviv, Y., H. B. Pollard, M. M. Gottesman. 1990. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J. Biol. Chem. 265:3975-3980.
2. Dey, S., M. Ramachandra, S. V. Ambudkar. 1997. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl. Acad. Sci. USA. 94:10594-10599.
3. Shapiro, A. B., and V. Ling. 1997. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur. J. Biochem. 250:122-129.
4. Higgins, C. F., and M. M. Gottesman. 1992. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17:18-21.
5. Nervi, P., X. Li-Blatter, A. Seelig. 2010. P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity. Biochim. Biophys. Acta. 1798:515-525.
6. Aller, S. G., J. Yu, G. Chang. 2009. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 323:1718-1722.
7. Ling, V., and R. M. Baker. 1978. Dominance of colchicine resistance in hybrid CHO cells. Somatic Cell Genet. 4:193-200.
8. Holland, I. B., and M. A. Blight. 1999. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293:381-399.
9. Pearce, H. L., A. R. Safa, W. T. Beck. 1989. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. Proc. Natl. Acad. Sci. USA. 86:5128-5132.
10. Seelig, A. 1998. A general pattern for substrate recognition by P-glycoprotein. Eur. J. Biochem. 251:252-261.
11. Seelig, A., X. L. Blatter, and F. Wohnsland. 2000. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int. J. Clin. Pharmacol. Ther. 38:111-121.
12. Shilling, R. A., H. Venter, H. W. van Veen. 2006. New light on multidrug binding by an ATP-binding-cassette transporter. Trends Pharmacol. Sci. 27:195-203.
13. Romsicki, Y., and F. J. Sharom. 1999. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry. 38:6887-6896.
14. Seelig, A., and E. Landwojtowicz. 2000. Structure-activity relationship of P-glycoprotein substrates and modifiers. Eur. J. Pharm. Sci. 12: 31-40.
15. Omote, H., and M. K. Al-Shawi. 2002. A novel electron paramagnetic resonance approach to determine the mechanism of drug transport by P-glycoprotein. J. Biol. Chem. 277:45688-45694.
16. Gatlik-Landwojtowicz, E., P. Aänismaa, and A. Seelig. 2006. Quantification and characterization of P-glycoprotein-substrate interactions. Biochemistry. 45:3020-3032.
17. Seelig, A., E. Landwojtowicz, X. Li Blatter. 2003. Towards P-glycoprotein structure-activity relationships. In Drug Bioavailability/ Estimation of Solubility, Permeability and Absorption. H. van der Waterbeemd, H. Lennernas, and P. Artursson, editors. Wiley/VCH, Weinheim, Germany. 461-492.
18. Li-Blatter, X., P. Nervi, and A. Seelig. 2009. Detergents as intrinsic P-glycoprotein substrates and inhibitors. Biochim. Biophys. Acta. 1788:2335-2344.
19. Omote, H., and M. K. Al-Shawi. 2006. Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. Biophys. J. 90:4046-4059.
20. Ekins, S., G. F. Ecker, P. W. Swaan. 2007. Future directions for drug transporter modeling. Xenobiotica. 37:1152-1170.
21. Seelig, A., editor. 2009. Toward Understanding P-Glycoprotein Structure-Activity Relationships. Wiley-VCH, Weinheim, Germany.
22. Seelig, A., and G. Gerebtzoff. 2006. Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding. Expert Opin. Drug Metab. Toxicol. 2:733-752.
23. Ambudkar, S. V., C. O. Cardarelli, W. D. Stein. 1997. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 272:21160-21166.
24. Heerklotz, H., and J. Seelig. 2000. Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. Biophys. J. 78:2435-2440.
25. Berthod, A., S. Tomer, and J. G. Dorsey. 2001. Polyoxyethylene alkyl ether nonionic surfactants: physicochemical properties and use for cholesterol determination in food. Talanta. 55:69-83.
26. Fischer, H., R. Gottschlich, and A. Seelig. 1998. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. 165:201-211.
27. Gerebtzoff, G., X. Li-Blatter, A. Seelig. 2004. Halogenation of drugs enhances membrane binding and permeation. ChemBioChem. 5:676-684.
28. Aänismaa, P., and A. Seelig. 2007. P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells. Biochemistry. 46:3394-3404.
29. Seelig, A. 1987. Local anesthetics and pressure: a comparison of dibu-caine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta. 899:196-204.
30. Litman, T., T. Zeuthen, W. D. Stein. 1997. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. Biochim. Biophys. Acta. 1361:159-168.
31. Heerklotz, H., H. Binder, A. Blume. 1997. Lipid/detergent Interaction Thermodynamics as a Function of Molecular Shape. J. Phys. Chem. B. 101:639-645.
32. Dawson, R. J., and K. P. Locher. 2006. Structure of a bacterial multidrug ABC transporter. Nature. 443:180-185.
33. Tanford, C., editor. 1980. The Hydrophobic Effect: Formation of Micelles and Biological Membranes. John Wiley & Sons, New York.
34. Meier, M., and J. Seelig. 2010. Lipid and peptide dynamics in membranes upon insertion of n-alkyl-β-D-glucopyranosides. Biophys. J. 98:1529-1538.
35. Gerebtzoff, G., and A. Seelig. 2006. In silico prediction ofblood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter. J. Chem. Inf. Model. 46:2638-2650.
36. Plevin, M. J., D. L. Bryce, and J. Boisbouvier. 2010. Direct detection of CH/pi interactions in proteins. Nat. Chem. 2:466-471.
37. Tóoth, G., S. G. Bowers, G. Probst. 2007. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance. Curr. Pharm. Des. 13:3476-3493.
38. O'Mara, M. L., and D. P. Tieleman. 2007. P-glycoprotein models of the apo and ATP-bound states based on homology with Sav1866 and MalK. FEBS Lett. 581:4217-4222.
39. Kol, M. A., A. van Dalen, B. de Kruijff. 2003. Translocation of phospholipids is facilitated by a subset of membrane-spanning proteins of the bacterial cytoplasmic membrane. J. Biol. Chem. 278:24586-24593.
40. Astumian, R. D., and I. Derényi. 1998. Fluctuation driven transport and models of molecular motors and pumps. Eur. Biophys. J. 27:474-489.
41. Reyes, C. L., and G. Chang. 2005. Structure of the ABC transporter MsbA in complex with ADP.vanadate and lipopolysaccharide. Science. 308:1028-1031. (Pubitemid 40664414)